Literature DB >> 3879564

The clinical findings in Leber's hereditary optic neuroretinopathy. Leber's disease.

E Nikoskelainen.   

Abstract

Leber's disease is a hereditary condition primarily affecting young men. The mechanism of inheritance is unknown. Increased tortuosity and capillary microangiopathy in the peripapillary capillary bed occur in varying degrees in asymptomatic persons in families with Leber's disease. These vascular abnormalities signify an increased risk of developing the acute form of the disease. Progressive microangiopathy is a threatening sign during the presymptomatic stage. In the acute and atrophic stages of Leber's disease striking neurovascular changes take place in the fundus of the eye involved. The ophthalmoscopic observations and nerve function studies in the asymptomatic, presymptomatic and acute stages suggest that Leber's disease starts as a vascular disease. The neuropathy appears later, around the time that vision begins to fail. Both eyes are involved but at varying intervals. At the end stage the patient has bilaterally finger counting vision and a large centrocecal scotoma caused by severe optic atrophy. Examinations of other persons in families with Leber's disease have shown that subclinical and mild forms of the disease also exist. Neurological signs and symptoms can occasionally occur. Cardiac abnormalities such as pre-excitation syndrome have been reported in Leber's disease. The aetiology and precipitating factors and effective treatment to prevent blindness in Leber's disease remain unsolved questions.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3879564

Source DB:  PubMed          Journal:  Trans Ophthalmol Soc U K        ISSN: 0078-5334


  11 in total

1.  Visual evoked potentials findings in non-affected subjects from a large Brazilian pedigree of 11778 Leber's hereditary optic neuropathy.

Authors:  Paula Yuri Sacai; Solange Rios Salomão; Valerio Carelli; Josenilson Martins Pereira; Rubens Belfort; Alfredo Arrigo Sadun; Adriana Berezovsky
Journal:  Doc Ophthalmol       Date:  2010-07-31       Impact factor: 2.379

2.  Molecular genetic analysis of a sporadic case of Leber hereditary optic neuropathy.

Authors:  N Howell; D McCullough; I Bodis-Wollner
Journal:  Am J Hum Genet       Date:  1992-02       Impact factor: 11.025

3.  Segregation of mitochondrial genomes in a heteroplasmic lineage with Leber hereditary optic neuroretinopathy.

Authors:  J Vilkki; M L Savontaus; E K Nikoskelainen
Journal:  Am J Hum Genet       Date:  1990-07       Impact factor: 11.025

4.  Analysis of mitochondrial DNA in Leber's hereditary optic neuropathy.

Authors:  J Poulton; M E Deadman; J Bronte-Stewart; W S Foulds; R M Gardiner
Journal:  J Med Genet       Date:  1991-11       Impact factor: 6.318

5.  Tobacco-alcohol amblyopia: magnetic resonance imaging findings.

Authors:  A G Kermode; G T Plant; D H Miller; B E Kendall; W I McDonald
Journal:  J Neurol Neurosurg Psychiatry       Date:  1989-12       Impact factor: 10.154

6.  Magnetic resonance imaging in Leber's optic neuropathy.

Authors:  A G Kermode; I F Moseley; B E Kendall; D H Miller; D G MacManus; W I McDonald
Journal:  J Neurol Neurosurg Psychiatry       Date:  1989-05       Impact factor: 10.154

7.  Mitochondrial gene mutations and human diseases: a prolegomenon.

Authors:  N Howell
Journal:  Am J Hum Genet       Date:  1994-08       Impact factor: 11.025

8.  A heteroplasmic LHON family: tissue distribution and transmission of the 11778 mutation.

Authors:  N Howell; M Xu; S Halvorson; I Bodis-Wollner; J Sherman
Journal:  Am J Hum Genet       Date:  1994-07       Impact factor: 11.025

9.  Mitochondrial DNA polymorphism in Finnish families with Leber's hereditary optic neuroretinopathy.

Authors:  J Vilkki; M L Savontaus; H Kalimo; E K Nikoskelainen
Journal:  Hum Genet       Date:  1989-06       Impact factor: 4.132

Review 10.  A review of primary hereditary optic neuropathies.

Authors:  M Votruba; S Aijaz; A T Moore
Journal:  J Inherit Metab Dis       Date:  2003       Impact factor: 4.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.